Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database. - Bewersdorf JP; Kewan T; Lanino L; Wei W; Rudra Gupta T; Stempel JM; Al Ali NH; DeZern AE; Sekeres MA; Uy GL; Urrutia S; Carraway HE; et al. (Blood cancer journal, 2026)